Advantage Multi For Dogs is a drug owned by ELANCO US INC. It is protected by 2 US drug patents filed in 2015. All patents have expired. Details of Advantage Multi For Dogs’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US6232328 | 12 May, 2015 | Expired |
Exclusivity Information
Advantage Multi For Dogs holds 1 exclusivity out of which 1 has expired. Details of Advantage Multi For Dogs's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Oct 24, 2016 |
About Advantage Multi For Dogs
Advantage Multi For Dogs is a drug
owned by ELANCO US INC.
Advantage Multi For Dogs uses
Imidacloprid, Moxidectin as the active
ingredients.
Active Ingredient:
Advantage Multi For Dogs uses
Imidacloprid,
Moxidectin
as the active ingredients.
Check out other Drugs and Companies using
Imidacloprid, Moxidectin ingredient.